News from Holden

Research

Melanoma vaccine trial to start at UI

Trial will test whether a personalized mRNA vaccine combined with an immunotherapy prevents melanoma from recurring

Research

New radiation therapy targets tumors more precisely

Software piloted at UI Health Care increases precision of MR-Linac technology  UI Health Care is the first

Research

Drinkable, carbon monoxide-infused foam enhances effectiveness of experimental cancer therapy

Did smokers do better than non-smokers in a clinical trial for an experimental cancer treatment? That was the intriguing question that led University of Iowa researchers and their colleagues to develop a drinkable, carbon monoxide-infused foam that boosted the effectiveness of the therapy, known as autophagy inhibition, in mice and human cells. The findings were recently published in the journal Advanced Science.

From the Director

Dorfman Award Nominations

November 16, 2023 To: Holden Comprehensive Cancer Center Members

Research

Holden oncologist receives NCI award for dedication to lung cancer clinical research

Muhammad Furqan, MD, medical oncologist in the University of Iowa Holden Comprehensive Cancer Center, is the recipie

Research

Faculty awarded 2023 ACS seed grant through Holden Comprehensive Cancer Center

Four early-career scientists have each been awarded a one-year, $40,000 American Cancer Society Institutional Researc

Innovation

Rare cancer care

Treating two girls with the same rare cancer is more than a coincidence for UI adult and pediatric specialists.